Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Incyte grabs a new PD-1 checkpoint drug in $900M deal with MacroGenics
Incyte grabs a new PD-1 checkpoint drug in $900M deal with MacroGenics
Incyte grabs a new PD-1 checkpoint drug in $900M deal with MacroGenics
Submitted by
admin
on October 25, 2017 - 9:44am
Source:
Endpoints
News Tags:
Incyte
PD-1 inhibitors
Macrogenics
MGA012
Headline:
Incyte grabs a new PD-1 checkpoint drug in $900M deal with MacroGenics
Do Not Allow Advertisers to Use My Personal information
